# A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis

> **NCT07427628** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Quan Dong Nguyen** · enrollment: 18 (estimated)

## Conditions studied

- Non Infectious Uveitis

## Interventions

- **BIOLOGICAL:** TRX103

## Key facts

- **NCT ID:** NCT07427628
- **Lead sponsor:** Quan Dong Nguyen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07427628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07427628, "A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07427628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*